Cargando…
PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma
Current treatment methods for patients diagnosed with gliomas have shown limited success. This is partly due to the lack of prognostic genes available to accurately predict disease outcomes. The aim of this study was to investigate novel prognostic genes based on the molecular profile of tumor sampl...
Autores principales: | Gao, Yuan-Feng, Zhu, Tao, Mao, Chen-Xue, Liu, Zhi-Xiong, Wang, Zhi-Bin, Mao, Xiao-Yuan, Li, Ling, Yin, Ji-Ye, Zhou, Hong-Hao, Liu, Zhao-Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133809/ https://www.ncbi.nlm.nih.gov/pubmed/27801851 http://dx.doi.org/10.3390/ijms17111808 |
Ejemplares similares
-
COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value
por: Gao, Yuan-Feng, et al.
Publicado: (2016) -
Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors
por: Cha, Yoon Jin, et al.
Publicado: (2020) -
Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas
por: Mellai, Marta, et al.
Publicado: (2013) -
Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi‐center study
por: Zhang, Anke, et al.
Publicado: (2021) -
Peptidylprolyl isomerase C (Ppic) regulates invariant Natural Killer T cell (iNKT) differentiation in mice
por: Paiva, Ricardo S., et al.
Publicado: (2021)